Member Info for Let-It-Roll

Looking good. Onward and upward!

Good to see you back Tilly!

Rising nicely on quite low volume too.. only 2.5m shares traded so far.

TimeTrade PriceVolumeValue 10:02:381.0030,000,000300.00kO16:28:391.128315,000,000169.25kO10:02:381.00-30,000,000-300.00kO16:28:391.1283-15,000,000-169.25k

So is that the whole £600k dumped now?

So chaps.. what is this:

Time Trade Price Volume Value

10:02:38 1.00 30,000,000 300.00k O

Just popped up after hours.

They've got £1.2m £600k Prevail. £600k ii.

Dillution is 4.65% not massive.

Pumpky. As you know.. Mint were CLN's. BIG difference!

Mint were CLN's BIG difference!

Two things. Funding is sorted. £1.2 million in total. £600k Prevail. £600k ii. And because it's an Institutional Investor the shares wont be forward sold or sold off.

So stop whining.

Two things. Funding is sorted. £1.2 million in total. £600k Prevail. £600k ii. And because it's an Institutional Investor the shares wont be forward sold or sold off.

So stop wetting yourself.

I think you will find if you read through the whole article that it is very aligned with Hemo. I think this could be sn indication of the forthcoming partnership and financial package with Hemo.

Remember MD Anderson approached Hemo!

And the brilliant scientific minds to which they refer, sounds like Vlad is very much one of those.

I would not be at all surprised to have a funding and partnership RNS now this week, following this MD Anderson press anouncement.

Let us not forget, that curing AML has pretty much been Vlad's lifes work. I am correct in thinking that his father died from AML? which is what motivated him to find a cure.

He's a bloody good scientist, and that is what is going to make this work. I have no doubt. Because the motivation is personal.

I can only imaging how excited Vlad is, at finally getting Hemo Cart T into Clinical Trials after all the upswings/downswings and fustrations of the last 4 years.

So, while some of us bicker and snipe at each other on here. Never, ever forget, that this is about peoples lives, and likely children's lives too next year.

That's why it needs to work. Money and share value are just a nice bonus. Saving lives is what's most important!

Vladislav SandlerVladislav Sandler

• 3rd+ • 3rd+

Entrepreneur, co-founder & CEO @ Hemogenyx Pharmaceuticals Plc | PhD, Neuroscience, synthetic biology, tikkun olam “kindness to the cruel is cruelty to the kind.”Entrepreneur, co-founder & CEO @ Hemogenyx Pharmaceuticals Plc | PhD, Neuroscience, synthetic biology, tikkun olam “kindness to the cruel is cruelty to the kind.”

3h • 3 hours ago

Follow

Another competitor CAR-T targeting CD123 on relapsed/refractory AML bites the dust. Hemogenyx Pharmaceuticals may end up being the "last man standing'.

You are unbelieveable Pumpky.... God i'd hate to live in your house.

Now the doom mongers can b*gger off! Clinical Trial is a go. Budget sorted.

We coukd be having a very very good Christmas!

Not in real terms... the published spread on LSE is huge atm.. so 1 buy at 1.6 sends it up. 1 sell at 1.3 sends it down

What a load of twaddle... is this the new doom and gloom you're trying to spread.

HEMO are not going private. Don't be ridiculous.

Easy to tell who is short here today and hurting with the rise in SP

750k is now 0.015

1m is quoting at 0.0154

Going to be a good day!

I Agree with Kingpin. Think we are really on the cusp now. Finally.

I will stick with my theory, that JV/non-dilutive funding was in negotiation, and has been for some time. These things in business take a looooong time because of due-diligence and getting things signed off higher up the chain.

The "placing" that now isn't happening, was in my view, a "bridging solution" if the JV/Non-dilutive funding took any longer to get signed off. A Plan B, if you like.

It is now no longer needed.

I expect a JV/Funding announcement RNS imminently, maybe even 7am tomorrow.